• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Can Neoadjuvant Therapy in Pancreatic Cancer Increase the Pool of Patients Eligible for Pancreaticoduodenectomy?

作者信息

Hackert Thilo, Ulrich Alexis, Büchler Markus W

机构信息

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, Heidelberg 69120, Germany.

Department of General, Visceral and Transplantation Surgery, University of Heidelberg, Im Neuenheimer Feld 110, Heidelberg 69120, Germany.

出版信息

Adv Surg. 2017 Sep;51(1):1-10. doi: 10.1016/j.yasu.2017.03.001. Epub 2017 Apr 28.

DOI:10.1016/j.yasu.2017.03.001
PMID:28797331
Abstract
摘要

相似文献

1
Can Neoadjuvant Therapy in Pancreatic Cancer Increase the Pool of Patients Eligible for Pancreaticoduodenectomy?胰腺癌的新辅助治疗能否增加适合胰十二指肠切除术的患者数量？
Adv Surg. 2017 Sep;51(1):1-10. doi: 10.1016/j.yasu.2017.03.001. Epub 2017 Apr 28.
2
Increased neutrophil-to-lymphocyte ratio after neoadjuvant therapy is associated with worse survival after resection of borderline resectable pancreatic ductal adenocarcinoma.新辅助治疗后中性粒细胞与淋巴细胞比值升高与临界可切除性胰腺导管腺癌切除术后较差的生存率相关。
Surgery. 2016 Nov;160(5):1288-1293. doi: 10.1016/j.surg.2016.04.039. Epub 2016 Jul 20.
3
Survival of patients with resectable pancreatic cancer who received neoadjuvant therapy.接受新辅助治疗的可切除胰腺癌患者的生存率。
Surgery. 2016 Mar;159(3):893-900. doi: 10.1016/j.surg.2015.09.018.
4
Overall survival is increased among stage III pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy compared to surgery first and adjuvant chemotherapy: An intention to treat analysis of the National Cancer Database.与先行手术及辅助化疗相比，接受新辅助化疗的III期胰腺腺癌患者总生存期有所延长：一项基于美国国立癌症数据库的意向性分析。
Surgery. 2016 Oct;160(4):1080-1096. doi: 10.1016/j.surg.2016.06.010. Epub 2016 Aug 10.
5
Pathological tumor response to neoadjuvant therapy in borderline resectable pancreatic cancer.临界可切除胰腺癌对新辅助治疗的病理肿瘤反应
Hepatobiliary Pancreat Dis Int. 2019 Aug;18(4):305-306. doi: 10.1016/j.hbpd.2019.06.006. Epub 2019 Jun 19.
6
Neoadjuvant docetaxel-based chemoradiation for resectable adenocarcinoma of the pancreas: New neoadjuvant regimen was safe and provided an interesting pathologic response.基于多西他赛的新辅助放化疗用于可切除胰腺癌：新辅助方案安全且呈现出有趣的病理反应。
Eur J Surg Oncol. 2010 Oct;36(10):987-92. doi: 10.1016/j.ejso.2010.07.003. Epub 2010 Sep 9.
7
Value of lymph node positivity in treatment planning for early stage pancreatic cancer.淋巴结阳性在早期胰腺癌治疗规划中的价值。
Surgery. 2017 Sep;162(3):557-567. doi: 10.1016/j.surg.2017.05.003. Epub 2017 Jun 27.
8
Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.新辅助化疗后对可切除边缘及局部进展期胰腺腺癌进行切除术。
Oncology. 2015;89(1):37-46. doi: 10.1159/000371745. Epub 2015 Mar 7.
9
Neoadjuvant therapy for resectable pancreatic cancer.可切除胰腺癌的新辅助治疗
Surg Oncol Clin N Am. 2004 Oct;13(4):639-61, ix. doi: 10.1016/j.soc.2004.06.007.
10
Phase I/II Trial of Neoadjuvant Oregovomab-based Chemoimmunotherapy Followed by Stereotactic Body Radiotherapy and Nelfinavir For Locally Advanced Pancreatic Adenocarcinoma.奥曲珠单抗为基础的新辅助化疗联合立体定向体部放疗和奈非那韦治疗局部进展期胰腺癌的 I/II 期临床试验。
Am J Clin Oncol. 2019 Oct;42(10):755-760. doi: 10.1097/COC.0000000000000599.

引用本文的文献

1
The Role of Neoadjuvant and Adjuvant Chemotherapy in Pancreatic Cancer.新辅助化疗和辅助化疗在胰腺癌中的作用
Indian J Surg Oncol. 2024 May;15(Suppl 2):315-321. doi: 10.1007/s13193-024-01938-6. Epub 2024 Apr 26.
2
Vascular Resections in Association With Pancreatic Resections for Locally Advanced Pancreatic Cancer.血管切除联合胰腺切除术治疗局部进展期胰腺癌。
In Vivo. 2022 Mar-Apr;36(2):1001-1006. doi: 10.21873/invivo.12793.
3
Continued Weight Loss and Sarcopenia Predict Poor Outcomes in Locally Advanced Pancreatic Cancer Treated with Chemoradiation.
持续体重减轻和肌肉减少症预示着接受放化疗的局部晚期胰腺癌患者预后不良。
Cancers (Basel). 2019 May 23;11(5):709. doi: 10.3390/cancers11050709.
4
Neoadjuvant and adjuvant chemotherapy in pancreatic cancer.胰腺癌的新辅助化疗和辅助化疗
Langenbecks Arch Surg. 2018 Dec;403(8):917-932. doi: 10.1007/s00423-018-1724-8. Epub 2018 Nov 5.